Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Promising, new prognostic markers of esophageal carcinomas.

Kapoor S.

APMIS. 2013 Oct;121(10):1011. doi: 10.1111/apm.12065. Epub 2013 Mar 20. No abstract available.

PMID:
23510410
2.

The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines.

Fujiwara D, Kato K, Nohara S, Iwanuma Y, Kajiyama Y.

Biochem Biophys Res Commun. 2013 May 17;434(4):773-8. doi: 10.1016/j.bbrc.2013.04.008. Epub 2013 Apr 18.

PMID:
23602898
3.

Expression analysis of iPS cell - inductive genes in esophageal squamous cell carcinoma by tissue microarray.

Shimada Y, Okumura T, Sekine S, Moriyama M, Sawada S, Matsui K, Yoshioka I, Hojo S, Yoshida T, Nagata T, Fukuoka J, Tsukada K.

Anticancer Res. 2012 Dec;32(12):5507-14.

PMID:
23225459
4.

Survivin expression in oesophageal squamous cell carcinoma: its prognostic impact and splice variant expression.

Takeno S, Yamashita S, Takahashi Y, Ono K, Kamei M, Moroga T, Kawahara K.

Eur J Cardiothorac Surg. 2010 Feb;37(2):440-5. doi: 10.1016/j.ejcts.2009.05.056. Epub 2009 Aug 20.

PMID:
19699104
5.

MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.

Yokobori T, Suzuki S, Tanaka N, Inose T, Sohda M, Sano A, Sakai M, Nakajima M, Miyazaki T, Kato H, Kuwano H.

Cancer Sci. 2013 Jan;104(1):48-54. doi: 10.1111/cas.12030. Epub 2012 Nov 8.

6.

Expression of immunoglobulin G in esophageal squamous cell carcinomas and its association with tumor grade and Ki67.

Zhang L, Hu S, Korteweg C, Chen Z, Qiu Y, Su M, Gu J.

Hum Pathol. 2012 Mar;43(3):423-34. doi: 10.1016/j.humpath.2011.05.020. Epub 2011 Aug 19.

PMID:
21855109
7.

Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma.

Fukuoka T, Hibi K, Nakao A.

Anticancer Res. 2006 Sep-Oct;26(5A):3333-5.

8.

Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma.

Matsuyama T, Nakanishi K, Hayashi T, Yoshizumi Y, Aiko S, Sugiura Y, Tanimoto T, Uenoyama M, Ozeki Y, Maehara T.

Cancer Sci. 2005 Mar;96(3):176-82.

9.

Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.

Fujita Y, Sakakura C, Shimomura K, Nakanishi M, Yasuoka R, Aragane H, Hagiwara A, Abe T, Inazawa J, Yamagishi H.

Hepatogastroenterology. 2003 Nov-Dec;50(54):1857-63.

PMID:
14696419
10.

Low expression of claudin-4 is associated with poor prognosis in esophageal squamous cell carcinoma.

Sung CO, Han SY, Kim SH.

Ann Surg Oncol. 2011 Jan;18(1):273-81. doi: 10.1245/s10434-010-1289-4. Epub 2010 Sep 14.

PMID:
20839069
11.

Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.

Okabayashi K, Fujita T, Miyazaki J, Okada T, Iwata T, Hirao N, Noji S, Tsukamoto N, Goshima N, Hasegawa H, Takeuchi H, Ueda M, Kitagawa Y, Kawakami Y.

Cancer Sci. 2012 Sep;103(9):1617-24. doi: 10.1111/j.1349-7006.2012.02355.x. Epub 2012 Jul 16.

12.

Identification and validation of DNA methylation markers to predict lymph node metastasis of esophageal squamous cell carcinomas.

Gyobu K, Yamashita S, Matsuda Y, Igaki H, Niwa T, Oka D, Kushima R, Osugi H, Lee S, Suehiro S, Ushijima T.

Ann Surg Oncol. 2011 Apr;18(4):1185-94. doi: 10.1245/s10434-010-1393-5. Epub 2010 Nov 2.

PMID:
21042947
13.
15.

DNA methylation is a key factor in understanding differentiation phenotype in esophageal squamous cell carcinoma.

Komatsu M, Sasaki H.

Epigenomics. 2014;6(6):567-9. doi: 10.2217/epi.14.56. No abstract available.

PMID:
25531249
16.

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.

Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, Ramos AH, Woo MS, Weir BA, Getz G, Beroukhim R, O'Kelly M, Dutt A, Rozenblatt-Rosen O, Dziunycz P, Komisarof J, Chirieac LR, Lafargue CJ, Scheble V, Wilbertz T, Ma C, Rao S, Nakagawa H, Stairs DB, Lin L, Giordano TJ, Wagner P, Minna JD, Gazdar AF, Zhu CQ, Brose MS, Cecconello I, Jr UR, Marie SK, Dahl O, Shivdasani RA, Tsao MS, Rubin MA, Wong KK, Regev A, Hahn WC, Beer DG, Rustgi AK, Meyerson M.

Nat Genet. 2009 Nov;41(11):1238-42. doi: 10.1038/ng.465. Epub 2009 Oct 4.

17.

PTCH gene expression as a potential marker for esophageal squamous cell carcinoma.

Ishiyama A, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A.

Anticancer Res. 2006 Jan-Feb;26(1A):195-8.

18.

Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma.

Zhou ZQ, Cao WH, Xie JJ, Lin J, Shen ZY, Zhang QY, Shen JH, Xu LY, Li EM.

BMC Cancer. 2009 Aug 22;9:291. doi: 10.1186/1471-2407-9-291.

19.

[Translational research and diagnostics in lung cancer].

Göke F, Perner S.

Pathologe. 2012 Nov;33 Suppl 2:269-72. doi: 10.1007/s00292-012-1664-y. Review. German.

PMID:
22968733
20.

Over-expression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression.

Ebihara Y, Miyamoto M, Shichinohe T, Kawarada Y, Cho Y, Fukunaga A, Murakami S, Uehara H, Kaneko H, Hashimoto H, Murakami Y, Itoh T, Okushiba S, Kondo S, Katoh H.

Dis Esophagus. 2004;17(2):150-4.

PMID:
15230729
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk